Eliem Therapeutics, Inc. Annual Return On Equity in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Eliem Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2020 to 2023.
  • Eliem Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -47 %, a 28.8% decline year-over-year.
  • Eliem Therapeutics, Inc. annual Return On Equity for 2023 was -31.5 %, a 2.6% increase from 2022.
  • Eliem Therapeutics, Inc. annual Return On Equity for 2022 was -32.3 %, a 57.5% increase from 2021.
  • Eliem Therapeutics, Inc. annual Return On Equity for 2021 was -76 %, a 151% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -31.5 +0.84 +2.6% Jan 1, 2023 Dec 31, 2023
2022 -32.3 +43.7 +57.5% Jan 1, 2022 Dec 31, 2022
2021 -76 -226 -151% Jan 1, 2021 Dec 31, 2021
2020 150 Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.